← Back to Search

Telehealth Palliative Care for Dementia (IBC Trial)

N/A
Waitlist Available
Research Sponsored by Thomas Jefferson University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Summary

This trial will test a new telehealth care model to see if it improves outcomes for people with dementia and their caregivers.

Who is the study for?
This trial is for adults over 18 with Alzheimer's or related dementias who have seen a Jefferson PCP in the last three years. Participants need access to telehealth technology and must speak English. It excludes those with traumatic brain injuries, current incarceration, homelessness, active antipsychotic medication use, or pregnancy.Check my eligibility
What is being tested?
The study tests a Telehealth Integrated Primary Care (TIPC) model developed for dementia patients during COVID-19. Over 12 months, it will assess patient outcomes, engagement with support services, advanced care planning activities and healthcare utilization patterns.See study design
What are the potential side effects?
Since this trial involves a non-medical intervention focusing on telehealth services rather than drugs or medical procedures, traditional side effects are not applicable. However, participants may experience issues related to the usability of technology or stress associated with adapting to new forms of communication.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Caregiver Support/Burden
Change in Decision-Making
Change in Disease-Related Quality of Life
+1 more
Secondary outcome measures
Interventional procedure

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Individuals in the intervention group will undergo a series of two telehealth video visits and a series of survey assessments at baseline, 3, 6, 9, and 12 months.
Group II: ControlActive Control1 Intervention
Individuals in the control group will continue with their usual standard of care and undergo a series of survey assessments at baseline, 3, 6, 9 and 12 months.

Find a Location

Who is running the clinical trial?

Independence Blue CrossUNKNOWN
6 Previous Clinical Trials
126,487 Total Patients Enrolled
Thomas Jefferson UniversityLead Sponsor
452 Previous Clinical Trials
148,837 Total Patients Enrolled

Media Library

Telehealth Integrated Primary Care (TIPC) Clinical Trial Eligibility Overview. Trial Name: NCT05524181 — N/A
Alzheimer's Disease Research Study Groups: Intervention, Control
Alzheimer's Disease Clinical Trial 2023: Telehealth Integrated Primary Care (TIPC) Highlights & Side Effects. Trial Name: NCT05524181 — N/A
Telehealth Integrated Primary Care (TIPC) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05524181 — N/A
~0 spots leftby Aug 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top